Pimenta Rafael Elias Farres, Yoshida Winston Bonetti, Rollo Hamilton Almeida, Sobreira Marcone Lima, Bertanha Matheus, Mariúba Jamil Victor de Oliveira, Jaldin Rodrigo Gibin, de Camargo Paula Angeleli Bueno
Universidade Estadual Paulista - UNESP, Faculdade de Medicina de Botucatu, Botucatu, SP, Brasil.
J Vasc Bras. 2016 Apr-Jun;15(2):138-141. doi: 10.1590/1677-5449.004215.
Heparin induced thrombocytopenia (HIT) is a serious complication of heparin anticoagulation and is associated with formation of anti-platelet factor 4. It usually occurs from the fifth day of treatment onwards, with a fall in platelet count of at least 50%. Venous or arterial thrombosis may occur as a result of concomitant platelet activation, with serious clinical repercussions. We present the case of a patient with antiphospholipid antibody syndrome who presented with acute arterial occlusion and was treated surgically and given unfractionated heparin intraoperatively and postoperatively. On the fifth day of anticoagulant treatment he exhibited a platelet count decreased by more than 50% compared to the count prior to heparin administration. The suspicion of heparin-induced thrombocytopenia and its diagnostic and therapeutic features are addressed in this therapeutic challenge paper.
肝素诱导的血小板减少症(HIT)是肝素抗凝治疗的一种严重并发症,与抗血小板因子4的形成有关。它通常在治疗的第五天起出现,血小板计数至少下降50%。由于伴随的血小板激活,可能会发生静脉或动脉血栓形成,产生严重的临床后果。我们报告一例抗磷脂抗体综合征患者,该患者出现急性动脉闭塞,接受了手术治疗,并在术中及术后给予了普通肝素。在抗凝治疗的第五天,他的血小板计数与肝素给药前相比下降了超过50%。本治疗挑战文章探讨了肝素诱导的血小板减少症的疑似情况及其诊断和治疗特点。